{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:12:28Z","timestamp":1794521548594,"version":"4.9.1"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The global rise in obesity, metabolic syndrome (MetS), insulin resistance (IR), and type 2 diabetes mellitus (T2DM) is reshaping the epidemiology of thyroid disorders, particularly thyroid nodular disease and differentiated thyroid cancer (DTC). This review summarizes emerging evidence linking metabolic dysfunction to thyroid nodule growth and tumorigenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Chronic hyperinsulinemia in IR states activates mitogenic pathways, including PI3K\/AKT\/mechanistic target of rapamycin (mTOR) and MAPK\/ERK. These effects are amplified in thyrocytes overexpressing insulin receptor isoform A (INSR-A) and insulin-like growth factor 1 receptor (IGF1R). Dysfunctional adipose tissue further increases risk through enhanced leptin signaling, reduced adiponectin-mediated AMPK activation, and persistent systemic inflammation and oxidative stress. Environmental factors such as endocrine-disrupting chemicals and gut microbiota alterations add additional susceptibility. Clinical evidence supports these mechanistic links: patients with thyroid nodules consistently show higher HOMA-IR values, and large cohort studies identify MetS as an independent predictor of thyroid nodularity. Female-specific susceptibility appears to be mediated by estrogen receptor activity, adipokine profiles, and postmenopausal fat redistribution. Therapeutically, metformin shows promise via AMPK activation and mTOR inhibition, exerting both metabolic and antiproliferative effects, although randomized trials specific to thyroid cancer outcomes remain limited. Concerns about GLP-1 receptor agonists and thyroid safety are largely theoretical; current data suggest their established cardiometabolic benefits may outweigh potential risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Converging epidemiological, molecular, and translational evidence underscores the complex interplay between metabolic dysfunction and thyroid diseases. Integrating metabolic health into prevention, risk stratification, and treatment strategies will be essential for advancing precision management of thyroid nodules and DTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cco.0000000000001202","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:00:28Z","timestamp":1762963228000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer"],"prefix":"10.1097","volume":"38","author":[{"given":"Stefano","family":"Iuliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"R1-20260213","doi-asserted-by":"crossref","first-page":"635614","DOI":"10.1155\/2012\/635614","article-title":"The insulin and igf-I pathway in endocrine glands carcinogenesis","volume":"2012","author":"Malaguarnera","year":"2012","journal-title":"J Oncol"},{"key":"R2-20260213","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s11739-021-02713-z","article-title":"Does insulin resistance trigger thyroid nodule?","volume":"16","author":"Demiral Sezer","year":"2021","journal-title":"Intern Emerg Med"},{"key":"R3-20260213","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2008.0062","article-title":"Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma","volume":"7","author":"Rezz\u00f3nico","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"R4-20260213","doi-asserted-by":"crossref","first-page":"e98135","DOI":"10.1371\/journal.pone.0098135","article-title":"Diabetes mellitus and risk of thyroid cancer: a meta-analysis","volume":"9","author":"Yeo","year":"2014","journal-title":"PLoS One"},{"key":"R5-20260213","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3904\/kjim.2015.273","article-title":"Prevalence of thyroid nodules and their associated clinical parameters: a large-scale, multicenter-based health checkup study","volume":"33","author":"Moon","year":"2018","journal-title":"Korean J Intern Med"},{"key":"R6-20260213","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fendo.2014.00215","article-title":"Type 3 deiodinase: role in cancer growth, stemness, and metabolism","volume":"5","author":"Ciavardelli","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R7-20260213","doi-asserted-by":"crossref","first-page":"E3258","DOI":"10.3390\/ijms20133258","article-title":"Activation of the IGF axis in thyroid cancer: implications for tumorigenesis and treatment","volume":"20","author":"Manzella","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R8-20260213","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-18-0310","article-title":"DDR1 regulates thyroid cancer cell differentiation via IGF-2\/IR-A autocrine signaling loop","volume":"26","author":"Vella","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"R9-20260213","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1210\/endo.142.12.8534","article-title":"Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-Ir receptor in the thyroid gland","volume":"142","author":"Cl\u00e9ment","year":"2001","journal-title":"Endocrinology"},{"key":"R10-20260213","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1530\/EJE-09-0410","article-title":"Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area","volume":"161","author":"Ayturk","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R11-20260213","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/thy.2015.0319","article-title":"Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies","volume":"26","author":"Kitahara","year":"2016","journal-title":"Thyroid"},{"key":"R12-20260213","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3904\/kjim.2016.31.1.98","article-title":"Relationship between metabolic syndrome and thyroid nodules in healthy Koreans","volume":"31","author":"Shin","year":"2016","journal-title":"Korean J Intern Med"},{"key":"R13-20260213","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41598-018-38203-0","article-title":"Weight change is significantly associated with risk of thyroid cancer: a nationwide population-based cohort study","volume":"9","author":"Kwon","year":"2019","journal-title":"Sci Rep"},{"key":"R14-20260213","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12902-025-01869-5","article-title":"Prevalence and predictors of thyroid nodules among adults: analyzing the association with metabolic syndrome in a cross-sectional study","volume":"25","author":"Abrishami","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"R15-20260213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/abr.abr_499_23","article-title":"Ultrasonic imaging of insulin resistance (HOMA-IR) and metabolic syndrome with and without thyroid nodules: a case-control patient-based study","volume":"14","author":"AmirAhmadi","year":"2025","journal-title":"Adv Biomed Res"},{"key":"R16-20260213","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hed.23848","article-title":"High prevalence of papillary thyroid cancer in Korean women with insulin resistance","volume":"38","author":"Bae","year":"2016","journal-title":"Head Neck"},{"key":"R17-20260213","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1158\/1055-9965.EPI-21-0255","article-title":"Association of metabolic health and central obesity with the risk of thyroid cancer: data from the Korean Genome and Epidemiology Study","volume":"31","author":"Nguyen","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R18-20260213","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13679-015-0155-x","article-title":"Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action","volume":"4","author":"Grams","year":"2015","journal-title":"Curr Obes Rep"},{"key":"R19-20260213","doi-asserted-by":"crossref","first-page":"102912","DOI":"10.1016\/j.ebiom.2020.102912","article-title":"Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance","volume":"59","author":"Arcidiacono","year":"2020","journal-title":"EBioMedicine"},{"key":"R20-20260213","doi-asserted-by":"crossref","first-page":"11137","DOI":"10.3390\/ijms222011137","article-title":"Insulin resistance and cancer: in search for a causal link","volume":"22","author":"Chiefari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R21-20260213","first-page":"188","article-title":"The PI3K\/Akt pathway in tumors of endocrine tissues","volume":"6","author":"Robbins","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R22-20260213","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fendo.2016.00073","article-title":"Cooperation between HMGA1 and HIF-1 Contributes to Hypoxia-Induced VEGF and Visfatin Gene Expression in 3T3-L1 Adipocytes","volume":"7","author":"Messineo","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R23-20260213","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/0008-5472.CAN-08-2641","article-title":"Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res"},{"key":"R24-20260213","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12598","article-title":"Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes","volume":"83","author":"Fan","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R25-20260213","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12013-012-9419-1","article-title":"Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma","volume":"65","author":"Cheng","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"R26-20260213","doi-asserted-by":"crossref","first-page":"597","DOI":"10.14336\/AD.2020.0919","article-title":"Adiponectin and thyroid cancer: insight into the association between adiponectin and obesity","volume":"12","author":"Zhou","year":"2021","journal-title":"Aging Dis"},{"key":"R27-20260213","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.2147\/CMAR.S199597","article-title":"The role of visfatin in cancer proliferation, angiogenesis, metastasis, drug resistance and clinical prognosis","author":"Lin","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R28-20260213","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0019-509X.175567","article-title":"Visfatin effects on telomerase gene expression in AGS gastric cancer cell line","volume":"52","author":"Mohammadi","year":"2015","journal-title":"Indian J Cancer"},{"key":"R29-20260213","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/cancers17060939","article-title":"Prognostic significance of key molecular markers in thyroid cancer: a systematic literature review and meta-analysis","volume":"17","author":"Nguyen","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R30-20260213","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4132\/jptm.2024.07.29","article-title":"TERT mutations and aggressive histopathologic characteristics of radioiodine-refractory papillary thyroid cancer","volume":"58","author":"Pyo","year":"2024","journal-title":"J Pathol Transl Med"},{"key":"R31-20260213","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156652410791316968","article-title":"Molecular pathways linking inflammation and cancer","volume":"10","author":"Mantovani","year":"2010","journal-title":"Curr Mol Med"},{"key":"R32-20260213","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","article-title":"Cancer related inflammation: the macrophage connection","volume":"267","author":"Sica","year":"2008","journal-title":"Cancer Lett"},{"key":"R33-20260213","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2014.03.015","article-title":"Endoplasmic reticulum stress in malignancy","volume":"25","author":"Clarke","year":"2014","journal-title":"Cancer Cell"},{"key":"R34-20260213","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41575-018-0025-6","article-title":"Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer","volume":"15","author":"Cani","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R35-20260213","doi-asserted-by":"crossref","first-page":"1349397","DOI":"10.3389\/fcimb.2024.1349397","article-title":"Alteration in gut microbiota is associated with immune imbalance in Graves\u2019 disease","volume":"14","author":"Liu","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"R36-20260213","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2025.1607388","article-title":"Gut microbiota: a promising new target in immune tolerance","volume":"16","author":"Almansour","year":"2025","journal-title":"Front Immunol"},{"key":"R37-20260213","doi-asserted-by":"crossref","first-page":"E1587","DOI":"10.3390\/microorganisms8101587","article-title":"Gut microbiota and immune system interactions","volume":"8","author":"Yoo","year":"2020","journal-title":"Microorganisms"},{"key":"R38-20260213","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/diagnostics14020166","article-title":"Coexistence of hashimoto's thyroiditis in differentiated thyroid cancer: post-operative monitoring of anti-thyroglobulin antibodies and assessment of treatment response","volume":"14","author":"Donnici","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"R39-20260213","doi-asserted-by":"crossref","first-page":"637826","DOI":"10.3389\/fendo.2020.637826","article-title":"Immune landscape of thyroid cancers: new insights","volume":"11","author":"Menicali","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R40-20260213","doi-asserted-by":"crossref","first-page":"1438235","DOI":"10.3389\/fimmu.2024.1438235","article-title":"Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Immunol"},{"key":"R41-20260213","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/ERC-21-0414","article-title":"Translating the immune microenvironment of thyroid cancer into clinical practice","volume":"29","author":"Cunha","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"R42-20260213","doi-asserted-by":"crossref","first-page":"1425873","DOI":"10.3389\/fimmu.2024.1425873","article-title":"Causal role of immune cells in thyroid cancer: a bidirectional Mendelian randomization study","volume":"15","author":"Fang","year":"2024","journal-title":"Front Immunol"},{"key":"R43-20260213","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/er.2015-1010","article-title":"EDC-2: the Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals","volume":"36","author":"Gore","year":"2015","journal-title":"Endocr Rev"},{"key":"R44-20260213","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.abb.2017.09.002","article-title":"Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway","volume":"633","author":"Zhang","year":"2017","journal-title":"Arch Biochem Biophys"},{"key":"R45-20260213","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/ijms26020814","article-title":"Environmental exposure to bisphenol A enhances invasiveness in papillary thyroid cancer","volume":"26","author":"Huang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R46-20260213","doi-asserted-by":"crossref","first-page":"120478","DOI":"10.1016\/j.envpol.2022.120478","article-title":"Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight\/obese patients","volume":"316","author":"Marotta","year":"2023","journal-title":"Environ Pollut"},{"key":"R47-20260213","doi-asserted-by":"crossref","first-page":"106016","DOI":"10.1016\/j.envint.2020.106016","article-title":"An epigenome-wide association study identifies multiple DNA methylation markers of exposure to endocrine disruptors","volume":"144","author":"Lu","year":"2020","journal-title":"Environ Int"},{"key":"R48-20260213","doi-asserted-by":"crossref","first-page":"108872","DOI":"10.1016\/j.envint.2024.108872","article-title":"Prenatal EDC exposure, DNA methylation, and early childhood growth: a prospective birth cohort study","volume":"190","author":"Lv","year":"2024","journal-title":"Environ Int"},{"key":"R49-20260213","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lfs.2015.10.022","article-title":"Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms","volume":"145","author":"Maqbool","year":"2016","journal-title":"Life Sci"},{"key":"R50-20260213","doi-asserted-by":"crossref","article-title":"Epigenetics meets endocrinology","author":"Zhang","DOI":"10.1677\/JME-10-0053"},{"key":"R51-20260213","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1007\/s13277-015-3315-4","article-title":"Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway","volume":"36","author":"Han","year":"2015","journal-title":"Tumour Biol"},{"key":"R52-20260213","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1158\/1078-0432.CCR-10-2243","article-title":"Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth","volume":"17","author":"Rocha","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R53-20260213","doi-asserted-by":"crossref","first-page":"e109852","DOI":"10.1371\/journal.pone.0109852","article-title":"Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes","volume":"9","author":"Tseng","year":"2014","journal-title":"PLoS One"},{"key":"R54-20260213","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/jc.2005-1210","article-title":"Thyrotropin suppression by metformin","volume":"91","author":"Vigersky","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-20260213","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fendo.2017.00314","article-title":"Insulin resistance: any role in the changing epidemiology of thyroid cancer?","volume":"8","author":"Malaguarnera","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R56-20260213","first-page":"403","article-title":"Glucagon-like peptide-1 receptor agonists and thyroid cancer: a narrative review","volume":"34","author":"Espinosa De Ycaza","year":"2024","journal-title":"Thyroid"},{"key":"R57-20260213","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4093\/dmj.2024.0105","article-title":"Use of glucagon-like peptide-1 receptor agonists does not increase the risk of cancer in patients with type 2 diabetes mellitus","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab J"},{"key":"R58-20260213","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1111\/dom.16489","article-title":"GLP-1 receptor agonists and the risk for cancer: a meta-analysis of randomized controlled trials","volume":"27","author":"Silverii","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"R59-20260213","doi-asserted-by":"crossref","first-page":"e55976","DOI":"10.2196\/55976","article-title":"Thyroid hyperplasia and neoplasm adverse events associated with glucagon-like peptide-1 receptor agonists in the food and drug administration adverse event reporting system: retrospective analysis","volume":"5","author":"Makunts","year":"2024","journal-title":"JMIRx Med"},{"key":"R60-20260213","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.3390\/ijms25084346","article-title":"Assessment of thyroid carcinogenic risk and safety profile of GLP1-RA semaglutide (ozempic) therapy for diabetes mellitus and obesity: a systematic literature review","volume":"25","author":"Feier","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R61-20260213","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/endocrines3030041","article-title":"The initial ATA risk classification, but not the ajCC\/TNM stage, predicts the persistence or relapse of differentiated thyroid cancer in long-term surveillance","volume":"3","author":"Giuliano","year":"2022","journal-title":"Endocrines"},{"key":"R62-20260213","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/endocrines1020010","article-title":"Malignancy analyses of thyroid nodules in patients subjected to surgery with cytological- and ultrasound-based risk stratification systems","volume":"1","author":"Giuliano","year":"2020","journal-title":"Endocrines"},{"key":"R63-20260213","doi-asserted-by":"crossref","first-page":"593479","DOI":"10.3389\/fonc.2021.593479","article-title":"Signal pathway of estrogen and estrogen receptor in the development of thyroid cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"R64-20260213","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1007\/s12032-012-0198-8","article-title":"Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-\u03b2","volume":"29","author":"Tang","year":"2012","journal-title":"Med Oncol"},{"key":"R65-20260213","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fendo.2014.00124","article-title":"Estrogens and stem cells in thyroid cancer","volume":"5","author":"Zane","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R66-20260213","doi-asserted-by":"crossref","first-page":"832163","DOI":"10.4061\/2011\/832163","article-title":"Leptin: a correlated peptide to papillary thyroid carcinoma?","volume":"2011","author":"Hedayati","year":"2011","journal-title":"J Thyroid Res"},{"key":"R67-20260213","doi-asserted-by":"crossref","first-page":"bqae030","DOI":"10.1210\/endocr\/bqae030","article-title":"Adiponectin inhibits the progression of obesity-associated papillary thyroid carcinoma through autophagy","volume":"165","author":"Li","year":"2024","journal-title":"Endocrinology"},{"key":"R68-20260213","first-page":"52","article-title":"The accumulation of visceral fat in postmenopausal women: the combined impact of prenatal genetics, epigenetics, and fat depot heterogeneity\u2014a descriptive review","author":"Zhang","year":"2025","journal-title":"CEOG"},{"key":"R69-20260213","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5603\/EP.2015.0049","article-title":"Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6","volume":"66","author":"Siemi\u0144ska","year":"2015","journal-title":"Endokrynol Pol"},{"key":"R70-20260213","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"R71-20260213","article-title":"Prospective validation of ATA risk score for papillary thyroid microcarcinoma: an ITCO Real-World Study","volume":"dgaf190","author":"De Leo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"R72-20260213","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/clinem\/dgac646","article-title":"Current controversies in low-risk differentiated thyroid cancer: reducing overtreatment in an era of overdiagnosis","volume":"108","author":"Ullmann","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R73-20260213","doi-asserted-by":"crossref","first-page":"101687","DOI":"10.1016\/j.beem.2022.101687","article-title":"Differentiated thyroid carcinoma: an update","volume":"37","author":"Houten","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R74-20260213","doi-asserted-by":"crossref","first-page":"906258","DOI":"10.3389\/fimmu.2022.906258","article-title":"Microbial dysbiosis in the gut drives systemic autoimmune diseases","volume":"13","author":"Mousa","year":"2022","journal-title":"Front Immunol"},{"key":"R75-20260213","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","article-title":"Current thyroid cancer trends in the United States","volume":"140","author":"Davies","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000001202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:00:38Z","timestamp":1770984038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000001202","relation":{},"ISSN":["1040-8746","1531-703X"],"issn-type":[{"value":"1040-8746","type":"print"},{"value":"1531-703X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}